Mesa Science Associates and Bryn Pharma Announce Initial Study of a New Approach to Treating Anaphylaxis
A non-clinical study regarding Nasal Administration of Epinephrine FREDERICK, MD. (PRWEB) NOVEMBER 13, 2019 On November 10, 2019, Mr. Michael Mesa, President, and CEO of Mesa Science Associates (MSA), announced the presentation of a non-clinical study regarding Nasal Administration of Epinephrine. The results were presented by Kenneth Dretchen Ph.D., CSO and[…]
Read more